Literature DB >> 14750895

Inversely planned intensity modulated radiotherapy of the breast including the internal mammary chain: a plan comparison study.

Christoph Thilmann1, Gabriele Sroka-Perez, Robert Krempien, Angelika Hoess, Michael Wannenmacher, Jürgen Debus.   

Abstract

The aim of this paper is to evaluate the benefit of inversely planned intensity modulated radiotherapy (IMRT) in the adjuvant irradiation of breast cancer when internal mammary lymph nodes are included in the treatment volume. 20 patients treated with 3D-planned conventional radiotherapy (CRT) following breast conserving surgery were included in the study. We chose 10 patients with left-sided and 10 patients with right-sided tumors. All treatment volumes included the internal mammary chain. For plan comparison to the applied CRT plan an inverse IMRT-plan in, step-and-shoot'-technique was calculated. For all patients IMRT resulted in an improved conformity of dose distribution to the target volume compared to CRT (mean COIN95: 0.798 vs. 0.514 with COIN95 = C1 * C2 (C1= fraction of CTV that is covered by > 95% of the prescribed dose and C2 = volume of CTV that is covered by > 95% of the prescribed dose/total volume that is covered by > 95% of the prescribed dose). In all cases with matching adjacent beams, the homogeneity in the target volume was improved. The volume of the ipsilateral lung irradiated with a dose higher than 20 Gy was reduced with IMRT from 24.6% to 13.1% compared to CRT. For left-sided target volume the heart volume with a dose higher than 30 Gy was reduced from 6.2% to 0.2%. The presented plan comparison study for irradiation of the breast and the parasternal lymph nodes showed a substantial improvement of the dose distribution by inversely planned IMRT compared to CRT. This is visible for the target volume, the ipsilateral lung and, in case of left-sided target volume, the heart. Despite an increase in integral dose to the entire normal tissue, the application of IMRT might be clinically advantageous in cases where no satisfying dose distribution can be obtained by CRT.

Entities:  

Mesh:

Year:  2004        PMID: 14750895     DOI: 10.1177/153303460400300108

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  11 in total

1.  Erratum to: Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-09       Impact factor: 9.261

2.  Esophageal cancer developed in a radiated field: can we reduce the risk of a poor prognosis cancer?

Authors:  Marina Schena; Angelo F Battaglia; Fernando Munoz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Secondary malignancies following radiotherapy for prostate cancer.

Authors:  Petros Sountoulides; Nikolaos Koletsas; Dimitris Kikidakis; Konstantinos Paschalidis; Nikolaos Sofikitis
Journal:  Ther Adv Urol       Date:  2010-06

4.  Implementation and experimental validation of a robust hybrid direct aperture optimization approach for mixed-beam radiotherapy.

Authors:  Emily Heath; Silvan Mueller; Gian Guyer; Alisha Duetschler; Olgun Elicin; Daniel Aebersold; Michael K Fix; Peter Manser
Journal:  Med Phys       Date:  2021-10-14       Impact factor: 4.506

5.  Evaluation of multiple breathing states using a multiple instance geometry approximation (MIGA) in inverse-planned optimization for locoregional breast treatment.

Authors:  Alexander Lin; Jean M Moran; Robin B Marsh; James M Balter; Benedick A Fraass; Daniel L McShan; Marc L Kessler; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

6.  Surface dose in the treatment of breast cancer with helical tomotherapy.

Authors:  Felix Zibold; Florian Sterzing; Gabriele Sroka-Perez; Kai Schubert; Katja Wagenknecht; Gerald Major; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

7.  Simultaneous integrated boost for adjuvant treatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial.

Authors:  Vasileios Askoxylakis; Alexandra D Jensen; Matthias F Häfner; Leonie Fetzner; Florian Sterzing; Joerg Heil; Christof Sohn; Johannes Hüsing; Uta Tiefenbacher; Frederik Wenz; Jürgen Debus; Holger Hof
Journal:  BMC Cancer       Date:  2011-06-15       Impact factor: 4.430

Review 8.  Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview.

Authors:  Damien C Weber; Carmen Ares; Antony J Lomax; John M Kurtz
Journal:  Radiat Oncol       Date:  2006-07-20       Impact factor: 3.481

Review 9.  Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast-conserving surgery and radiation therapy: a review.

Authors:  Robert E Beck; Leonard Kim; Ning J Yue; Bruce G Haffty; Atif J Khan; Sharad Goyal
Journal:  Front Oncol       Date:  2014-11-14       Impact factor: 6.244

10.  IMRT sparing of normal tissues in locoregional treatment of breast cancer.

Authors:  Jean-Michel Caudrelier; Joanne Meng; Bernd Esche; Laval Grimard; Terrence Ruddy; Kayvan Amjadi
Journal:  Radiat Oncol       Date:  2014-07-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.